Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 16,528 | -59,995 | -45,001 | -13,538 | -16,933 |
| Depreciation Amortization | 2,951 | 10,033 | 7,085 | 4,153 | 1,916 |
| Accounts receivable | -615 | 2,353 | 1,759 | 4,909 | -2,646 |
| Accounts payable and accrued liabilities | -1,422 | -7,107 | -6,655 | -7,416 | -1,928 |
| Other Working Capital | -9,678 | 13,160 | 17,222 | -5,464 | -5,430 |
| Other Operating Activity | 7,897 | 42,329 | 31,998 | 22,044 | 13,481 |
| Operating Cash Flow | $15,661 | $773 | $6,408 | $4,688 | $-11,540 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -46 | -23 | -12 | N/A |
| Purchase Of Investment | -10,696 | -29,826 | -24,430 | -16,376 | N/A |
| Sale Of Investment | 5,395 | 73,275 | 57,033 | 51,546 | 34,377 |
| Purchase Sale Intangibles | N/A | -10,000 | -10,000 | -10,000 | N/A |
| Other Investing Activity | 0 | -10,000 | -10,000 | -10,000 | 0 |
| Investing Cash Flow | $-5,301 | $33,403 | $22,580 | $25,158 | $34,377 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 8,444 | 8,444 | 8,444 | N/A |
| Debt Repayment | N/A | -8,444 | -8,444 | -8,444 | N/A |
| Common Stock Issued | N/A | 68 | 45 | 2 | N/A |
| Other Financing Activity | 0 | -10,000 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $-9,932 | $45 | $2 | $N/A |
| Beginning Cash Position | 97,454 | 73,210 | 73,210 | 73,210 | 73,210 |
| End Cash Position | 107,814 | 97,454 | 102,243 | 103,058 | 96,047 |
| Net Cash Flow | $10,360 | $24,244 | $29,033 | $29,848 | $22,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | 15,661 | 773 | 6,408 | 4,688 | -11,540 |
| Capital Expenditure | N/A | -46 | -23 | -12 | N/A |
| Free Cash Flow | 15,661 | 727 | 6,385 | 4,676 | -11,540 |